Sep 4, 2014

Clockwork heart pacemaker does away with batteries

Swiss engineers, famous for making the world’s finest watches, are turning their hands to cardiology with a prototype battery-free pacemaker based on a self-winding wristwatch. Current pacemakers, which help the heart beat more regularly, offer a lifeline for many patients with cardiac problems but ...

Sep 4, 2014

Madoff's last surviving son, Andrew, dies

Andrew Madoff, Bernard Madoff’s last surviving son, died of cancer on Wednesday, years after turning his father in and insisting he had been duped like the rest of the world into believing history’s most notorious Ponzi king was an honest financier. Andrew Madoff, 48, ...

Japanese researchers develop 30-minute Ebola test

Sep 3, 2014

Japanese researchers develop 30-minute Ebola test

Japanese researchers say they have developed a new method to detect the presence of the Ebola virus in just 30 minutes, speeding up the ability to diagnose infections of the deadly disease. Professor Jiro Yasuda and his team at Nagasaki University say their process ...

Sep 3, 2014

U.S. missionary doctor in Liberia tests positive for Ebola

An American doctor working in Liberia has tested positive for the Ebola virus after working with obstetrics patients at a missionary hospital in Monrovia, the Christian organization SIM USA said on Tuesday. The North Carolina-based group did not identify the doctor, who had not ...

U.N. issues dire warning about food shortages in Ebola-hit nations

Sep 2, 2014

U.N. issues dire warning about food shortages in Ebola-hit nations

Labor shortages and disrupted cross-border trade caused by the deadly Ebola outbreak have sparked “grave food security concerns” in the worst-hit countries, the United Nations said Tuesday. Restrictions on movement in Guinea, Liberia and Sierra Leone has led to panic buying, food shortages and ...

Aug 31, 2014

Novel heart failure drug shows big promise

A new study reports one of the biggest potential advances against heart failure in more than a decade: a first-of-a-kind, experimental drug that lowered the chances of death or hospitalization by about 20 percent. Doctors say the Novartis drug — which doesn’t have a ...